drug

TableSoccer

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by University Medical Center Goettingen
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Enhancing Synaptic Plasticity and Cognition in Schizophrenia
NCT01776112—Completed

KOLs & investigators

3
Peter G. Falkai, Prof. Dr.KOL score 8
Berend Malchow, MD
Andrea Schmitt, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University Medical Center Goettingen
company
trial
Enhancing Synaptic Plasticity and Cognition in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Cognition Disorders
indication
KOL
Peter G. Falkai, Prof. Dr.
KOL score 8
person
Berend Malchow, MD
KOL score —
person
Andrea Schmitt, MD, PhD
KOL score —
person